SuperworthSunshine Biopharma shares outstanding SBFM
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2025
- 360.5K
- On a year earlier
- +8714.2%
- more shares
Sunshine Biopharma had 360.5K diluted shares outstanding on average in Q2 FY25, the quarter to Jun 30, 2025.
That is 8714.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 164.5K | +13715% |
| FY2023 | 1.2K | +7% |
| FY2022 | 1.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY25 | 360.5K | +8714% | |
| Q1 FY25 | 270.3K | +8331% | |
| Q4 FY24 | 164.5K | +13715% | |
| Q3 FY24 | 126.8K | +9768% | |
| Q2 FY24 | 4.1K | −100% | |
| Q1 FY24 | 3.2K | +191% | |
| Q4 FY23 | 1.2K | +7% | |
| Q3 FY23 | 1.3K | +36% | |
| Q2 FY23 | 1.3M | +159842% | |
| Q1 FY23 | 1.1K | +318% | |
| Q4 FY22 | 1.1K | n/a | |
| Q3 FY22 | 944 | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Sunshine Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.